Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
5 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
bioAffinity Technologies completed a financing raising about $4 million via a Securities Purchase Agreement, selling common shares and pre-funded warrants and adding warrants under the offering terms.
bioAffinity Technologies closed a previously announced registered direct offering and concurrent private placement that raised about $4 million before fees and expenses. The company said it plans to use the net proceeds for working capital, CyPath Lung sales support and general corporate purposes.
Dow Jones Newswires compiled a roundup of private markets headlines and stories published on the last trading day. The package includes financing, IPO, acquisition, recall and partnership updates.
bioAffinity Technologies said it entered a definitive agreement for a registered direct offering and concurrent private placement expected to raise about $4 million before fees and expenses. The company said it plans to use the net proceeds for working capital, CyPath Lung sales support and general corporate purposes.
bioAffinity Technologies, Inc. said it has agreed with an institutional investor to sell common stock in a registered direct financing and a concurrent at-the-market private placement under Nasdaq rules.